JP2016514710A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016514710A5 JP2016514710A5 JP2016503522A JP2016503522A JP2016514710A5 JP 2016514710 A5 JP2016514710 A5 JP 2016514710A5 JP 2016503522 A JP2016503522 A JP 2016503522A JP 2016503522 A JP2016503522 A JP 2016503522A JP 2016514710 A5 JP2016514710 A5 JP 2016514710A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- oxo
- dihydro
- pyrazolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 136
- -1 aminocarbonyloxy Chemical group 0.000 claims 43
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 39
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 24
- 125000003118 aryl group Chemical group 0.000 claims 15
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 14
- 125000001072 heteroaryl group Chemical group 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000003282 alkyl amino group Chemical group 0.000 claims 12
- RLZJFTOYCVIYLE-UHFFFAOYSA-N oxane-4-carbonitrile Chemical compound N#CC1CCOCC1 RLZJFTOYCVIYLE-UHFFFAOYSA-N 0.000 claims 12
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 208000006673 asthma Diseases 0.000 claims 9
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 5
- 206010003246 arthritis Diseases 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000004404 heteroalkyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 3
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 claims 3
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 3
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 3
- 125000005055 alkyl alkoxy group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 230000005764 inhibitory process Effects 0.000 claims 3
- 125000004501 isothiazol-5-yl group Chemical group S1N=CC=C1* 0.000 claims 3
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 2
- PHABQEUMBQLONZ-UHFFFAOYSA-N 3-[3-(4-tert-butylsulfonylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxepane-4-carbonitrile Chemical compound C(C)(C)(C)S(=O)(=O)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1COCCCC1C#N PHABQEUMBQLONZ-UHFFFAOYSA-N 0.000 claims 2
- FZZHOXMWASTDDC-UHFFFAOYSA-N 3-[3-[4-(2,6-dimethylmorpholin-4-yl)sulfonylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1CN(CC(C)O1)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 FZZHOXMWASTDDC-UHFFFAOYSA-N 0.000 claims 2
- DATDNGCXBBJWGO-UHFFFAOYSA-N 3-[3-[4-[1-(dimethylamino)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CN(C)C(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)C(F)(F)F DATDNGCXBBJWGO-UHFFFAOYSA-N 0.000 claims 2
- RLLHQSRIRJBRFP-UHFFFAOYSA-N 5-[3-(4-tert-butylsulfonylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxepane-4-carbonitrile Chemical compound C(C)(C)(C)S(=O)(=O)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1C(CCOCC1)C#N RLLHQSRIRJBRFP-UHFFFAOYSA-N 0.000 claims 2
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- IOXDCCCOLUVQMN-UHFFFAOYSA-N N-tert-butyl-4-[[1-(4-cyanooxan-3-yl)-4-oxo-5H-pyrazolo[4,3-c]pyridin-3-yl]amino]-N-methylbenzenesulfonamide Chemical compound CN(C(C)(C)C)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 IOXDCCCOLUVQMN-UHFFFAOYSA-N 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 claims 2
- 230000000414 obstructive effect Effects 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 208000023504 respiratory system disease Diseases 0.000 claims 2
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000004889 1-methylethylamino group Chemical group CC(C)N* 0.000 claims 1
- NWQCVVREYYCLTJ-UHFFFAOYSA-N 3-(3-anilino-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl)oxane-4-carbonitrile Chemical compound O=c1[nH]ccc2n(nc(Nc3ccccc3)c12)C1COCCC1C#N NWQCVVREYYCLTJ-UHFFFAOYSA-N 0.000 claims 1
- DXVXXWQBLURGJX-UHFFFAOYSA-N 3-[3-(3,4-dimethylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound Cc1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1C DXVXXWQBLURGJX-UHFFFAOYSA-N 0.000 claims 1
- CDYRUVDODWFAHB-UHFFFAOYSA-N 3-[3-(4-chloro-3-methylsulfonylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CS(=O)(=O)c1cc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)ccc1Cl CDYRUVDODWFAHB-UHFFFAOYSA-N 0.000 claims 1
- MSLAFAQZAUHBCE-UHFFFAOYSA-N 3-[3-(4-cyano-3-fluoroanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound Fc1cc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)ccc1C#N MSLAFAQZAUHBCE-UHFFFAOYSA-N 0.000 claims 1
- LMBKZSAOJSEFTR-UHFFFAOYSA-N 3-[3-(4-cyanoanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound C(#N)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N LMBKZSAOJSEFTR-UHFFFAOYSA-N 0.000 claims 1
- VCNURNCZJFPRHP-UHFFFAOYSA-N 3-[3-(4-fluoro-3-methoxyanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound COc1cc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)ccc1F VCNURNCZJFPRHP-UHFFFAOYSA-N 0.000 claims 1
- XTMVJGRVZLDCNX-UHFFFAOYSA-N 3-[3-(4-fluoro-3-methylsulfinylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound FC1=C(C=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N)S(=O)C XTMVJGRVZLDCNX-UHFFFAOYSA-N 0.000 claims 1
- DUNNDRSGOPPNJN-UHFFFAOYSA-N 3-[3-(4-methylsulfonylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CS(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 DUNNDRSGOPPNJN-UHFFFAOYSA-N 0.000 claims 1
- LDLPWZKLUCQRQL-UHFFFAOYSA-N 3-[3-(4-tert-butylsulfonylanilino)-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound C(C)(C)(C)S(=O)(=O)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1COCCC1C#N LDLPWZKLUCQRQL-UHFFFAOYSA-N 0.000 claims 1
- FAEYPXVCHWMLMH-UHFFFAOYSA-N 3-[3-[(2-fluoropyridin-4-yl)amino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound Fc1cc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)ccn1 FAEYPXVCHWMLMH-UHFFFAOYSA-N 0.000 claims 1
- VXJWYZRDVLGCKC-UHFFFAOYSA-N 3-[3-[(2-methyl-1,3-benzothiazol-6-yl)amino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1=NC2=CC=C(NC3=NN(C4COCCC4C#N)C4=C3C(=O)NC=C4)C=C2S1 VXJWYZRDVLGCKC-UHFFFAOYSA-N 0.000 claims 1
- UDZITTSXSXGDKJ-UHFFFAOYSA-N 3-[3-[4-(1-amino-2,2,2-trifluoroethyl)anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound NC(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)C(F)(F)F UDZITTSXSXGDKJ-UHFFFAOYSA-N 0.000 claims 1
- LSFCHWZFVUIURS-UHFFFAOYSA-N 3-[3-[4-(2,2-dimethylmorpholin-4-yl)sulfonylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1(C)CN(CCO1)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 LSFCHWZFVUIURS-UHFFFAOYSA-N 0.000 claims 1
- NKAVHSSKHLLZAC-UHFFFAOYSA-N 3-[3-[4-(2,2-dimethylpyrrolidin-1-yl)sulfonylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1(C)CCCN1S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 NKAVHSSKHLLZAC-UHFFFAOYSA-N 0.000 claims 1
- TWFDWXGERBQRFS-UHFFFAOYSA-N 3-[3-[4-(2,3-dimethylbutan-2-ylsulfonyl)anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound O=C1NC=CC2=C1C(=NN2C1COCCC1C#N)NC1=CC=C(C=C1)S(=O)(=O)C(C(C)C)(C)C TWFDWXGERBQRFS-UHFFFAOYSA-N 0.000 claims 1
- XCJUMLLVKNXZCG-UHFFFAOYSA-N 3-[3-[4-(2-aminopropan-2-yl)anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound NC(C)(C)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N XCJUMLLVKNXZCG-UHFFFAOYSA-N 0.000 claims 1
- YWIXRQRPWHUIDZ-UHFFFAOYSA-N 3-[3-[4-(2-methylazetidin-1-yl)sulfonylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1CCN1S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 YWIXRQRPWHUIDZ-UHFFFAOYSA-N 0.000 claims 1
- NSAPRGTZLWOKML-UHFFFAOYSA-N 3-[3-[4-(2-methylbutan-2-ylsulfonyl)anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC(CC)(C)S(=O)(=O)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N NSAPRGTZLWOKML-UHFFFAOYSA-N 0.000 claims 1
- WEHZPWUKUMWGGZ-UHFFFAOYSA-N 3-[3-[4-(2-methylmorpholin-4-yl)sulfonylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1CN(CCO1)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 WEHZPWUKUMWGGZ-UHFFFAOYSA-N 0.000 claims 1
- ZJEWGVXYZXEGSA-UHFFFAOYSA-N 3-[3-[4-(3-methylazetidin-1-yl)sulfonylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1CN(C1)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 ZJEWGVXYZXEGSA-UHFFFAOYSA-N 0.000 claims 1
- FPPBCXXQYOINRJ-UHFFFAOYSA-N 3-[3-[4-(4,4-difluoropiperidine-1-carbonyl)-3-methylanilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound FC1(CCN(CC1)C(=O)C1=C(C=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1COCCC1C#N)C)F FPPBCXXQYOINRJ-UHFFFAOYSA-N 0.000 claims 1
- FPISKLKIWBBDAB-UHFFFAOYSA-N 3-[3-[4-(5,5-dimethyl-3-oxo-2-oxabicyclo[2.2.2]octan-1-yl)anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1(C2C(OC(C1)(CC2)C2=CC=C(C=C2)NC2=NN(C1=C2C(NC=C1)=O)C1COCCC1C#N)=O)C FPISKLKIWBBDAB-UHFFFAOYSA-N 0.000 claims 1
- IDWYKKGXCFTFGK-UHFFFAOYSA-N 3-[3-[4-(azetidin-1-ylsulfonyl)anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound O=c1[nH]ccc2n(nc(Nc3ccc(cc3)S(=O)(=O)N3CCC3)c12)C1COCCC1C#N IDWYKKGXCFTFGK-UHFFFAOYSA-N 0.000 claims 1
- UZFQQJCBGJXNFG-UHFFFAOYSA-N 3-[3-[4-[1-(2,2-dimethylpropylamino)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC(CNC(C(F)(F)F)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1COCCC1C#N)(C)C UZFQQJCBGJXNFG-UHFFFAOYSA-N 0.000 claims 1
- XAILBBYMKDLIKC-UHFFFAOYSA-N 3-[3-[4-[1-(azetidin-1-yl)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound N1(CCC1)C(C(F)(F)F)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1COCCC1C#N XAILBBYMKDLIKC-UHFFFAOYSA-N 0.000 claims 1
- HICWURMPDPCWRE-UHFFFAOYSA-N 3-[3-[4-[1-(cyclobutylamino)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound FC(F)(F)C(NC1CCC1)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 HICWURMPDPCWRE-UHFFFAOYSA-N 0.000 claims 1
- WCMAJBONEJRSME-UHFFFAOYSA-N 3-[3-[4-[1-(cyclopentylamino)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound C1(CCCC1)NC(C(F)(F)F)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N WCMAJBONEJRSME-UHFFFAOYSA-N 0.000 claims 1
- UVJKFXUPMZJTBX-UHFFFAOYSA-N 3-[3-[4-[1-(cyclopropylamino)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound FC(F)(F)C(NC1CC1)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 UVJKFXUPMZJTBX-UHFFFAOYSA-N 0.000 claims 1
- FUGMNWHQRGIZSH-UHFFFAOYSA-N 3-[3-[4-[1-(ethylamino)-2,2,2-trifluoroethyl]anilino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound C(C)NC(C(F)(F)F)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N FUGMNWHQRGIZSH-UHFFFAOYSA-N 0.000 claims 1
- RYCVMXONAHTSQD-UHFFFAOYSA-N 3-[3-[[3-methyl-2-oxo-3-(propan-2-ylamino)-1H-indol-6-yl]amino]-4-oxo-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC(C)NC1(C)C(=O)Nc2cc(Nc3nn(C4COCCC4C#N)c4cc[nH]c(=O)c34)ccc12 RYCVMXONAHTSQD-UHFFFAOYSA-N 0.000 claims 1
- QHEVCBUOBQXHRF-UHFFFAOYSA-N 3-[4-oxo-3-(4-propan-2-ylsulfonylanilino)-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC(C)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 QHEVCBUOBQXHRF-UHFFFAOYSA-N 0.000 claims 1
- XTGCIKKWHWYMIJ-UHFFFAOYSA-N 3-[4-oxo-3-[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound O=C1NC=CC2=C1C(=NN2C1COCCC1C#N)NC1=CC=C(C=C1)C(C(F)(F)F)(C)O XTGCIKKWHWYMIJ-UHFFFAOYSA-N 0.000 claims 1
- IFYXHVRGQCIDKX-UHFFFAOYSA-N 3-[4-oxo-3-[4-(2,2,2-trifluoro-1-hydroxy-1-pyridin-2-ylethyl)anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound OC(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)(c1ccccn1)C(F)(F)F IFYXHVRGQCIDKX-UHFFFAOYSA-N 0.000 claims 1
- SBLQVHXFSYAJFC-UHFFFAOYSA-N 3-[4-oxo-3-[4-(2,2,2-trifluoro-1-hydroxy-1-pyridin-4-ylethyl)anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound OC(c1ccncc1)(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)C(F)(F)F SBLQVHXFSYAJFC-UHFFFAOYSA-N 0.000 claims 1
- JEHLIIJLLCMZCZ-UHFFFAOYSA-N 3-[4-oxo-3-[4-(2,2,2-trifluoro-1-piperazin-1-ylethyl)anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound O=C1NC=CC2=C1C(=NN2C1COCCC1C#N)NC1=CC=C(C=C1)C(C(F)(F)F)N1CCNCC1 JEHLIIJLLCMZCZ-UHFFFAOYSA-N 0.000 claims 1
- TVAFKVGYDWDABI-UHFFFAOYSA-N 3-[4-oxo-3-[4-(2,2,2-trifluoro-1-pyrrolidin-1-ylethyl)anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound O=C1NC=CC2=C1C(=NN2C1COCCC1C#N)NC1=CC=C(C=C1)C(C(F)(F)F)N1CCCC1 TVAFKVGYDWDABI-UHFFFAOYSA-N 0.000 claims 1
- QOVQCZIHBVAUAW-UHFFFAOYSA-N 3-[4-oxo-3-[4-[2,2,2-trifluoro-1-(2-methylpropylamino)ethyl]anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound O=C1NC=CC2=C1C(=NN2C2COCCC2C#N)NC2=CC=C(C=C2)C(C(F)(F)F)NCC(C)C QOVQCZIHBVAUAW-UHFFFAOYSA-N 0.000 claims 1
- UNFLXRVOHAFEMD-UHFFFAOYSA-N 3-[4-oxo-3-[4-[2,2,2-trifluoro-1-(2-methylpyrrolidin-1-yl)ethyl]anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC1CCCN1C(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)C(F)(F)F UNFLXRVOHAFEMD-UHFFFAOYSA-N 0.000 claims 1
- NAITXMCGULBVPE-UHFFFAOYSA-N 3-[4-oxo-3-[4-[2,2,2-trifluoro-1-(4-methylpiperazin-1-yl)ethyl]anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CN1CCN(CC1)C(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)C(F)(F)F NAITXMCGULBVPE-UHFFFAOYSA-N 0.000 claims 1
- VJNMTKUCKLBHNN-UHFFFAOYSA-N 3-[4-oxo-3-[4-[2,2,2-trifluoro-1-(propan-2-ylamino)ethyl]anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC(C)NC(c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1)C(F)(F)F VJNMTKUCKLBHNN-UHFFFAOYSA-N 0.000 claims 1
- GNQRXVPCERRFFA-UHFFFAOYSA-N 3-[4-oxo-3-[4-[2-(propan-2-ylamino)propan-2-yl]anilino]-5H-pyrazolo[4,3-c]pyridin-1-yl]oxane-4-carbonitrile Chemical compound CC(C)(NC(C)C)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C2COCCC2C#N GNQRXVPCERRFFA-UHFFFAOYSA-N 0.000 claims 1
- SJDCORZYFJDIGG-UHFFFAOYSA-N 4-[[1-(4-cyanooxan-3-yl)-4-oxo-5H-pyrazolo[4,3-c]pyridin-3-yl]amino]-N,N-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)c1ccc(Nc2nn(C3COCCC3C#N)c3cc[nH]c(=O)c23)cc1 SJDCORZYFJDIGG-UHFFFAOYSA-N 0.000 claims 1
- 208000000884 Airway Obstruction Diseases 0.000 claims 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 1
- 102000042838 JAK family Human genes 0.000 claims 1
- 108091082332 JAK family Proteins 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- KMMWOCNAVRZJCV-UHFFFAOYSA-N N-tert-butyl-4-[[1-(4-cyanooxan-3-yl)-4-oxo-5H-pyrazolo[4,3-c]pyridin-3-yl]amino]-N-ethylbenzenesulfonamide Chemical compound C(C)(C)(C)N(S(=O)(=O)C1=CC=C(C=C1)NC1=NN(C2=C1C(NC=C2)=O)C1COCCC1C#N)CC KMMWOCNAVRZJCV-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000020410 Psoriasis-related juvenile idiopathic arthritis Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000005277 alkyl imino group Chemical group 0.000 claims 1
- 201000009961 allergic asthma Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000023819 chronic asthma Diseases 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004639 dihydroindenyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 1
- 125000006263 dimethyl aminosulfonyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 claims 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000428 dust Substances 0.000 claims 1
- 125000006534 ethyl amino methyl group Chemical group [H]N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 208000024711 extrinsic asthma Diseases 0.000 claims 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 claims 1
- 201000010659 intrinsic asthma Diseases 0.000 claims 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000006513 pyridinyl methyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361803226P | 2013-03-19 | 2013-03-19 | |
| US61/803,226 | 2013-03-19 | ||
| PCT/CN2014/000298 WO2014146492A1 (en) | 2013-03-19 | 2014-03-19 | N-(2-cyano heterocyclyl)pyrazolo pyridones as janus kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016514710A JP2016514710A (ja) | 2016-05-23 |
| JP2016514710A5 true JP2016514710A5 (cg-RX-API-DMAC7.html) | 2017-04-13 |
| JP6322275B2 JP6322275B2 (ja) | 2018-05-09 |
Family
ID=51579321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503522A Active JP6322275B2 (ja) | 2013-03-19 | 2014-03-19 | ヤヌスキナーゼ阻害剤としてのｎ−（２−シアノヘテロシクリル）ピラゾロピリドン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9957265B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2976338B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6322275B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20150130311A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105189497B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014234908B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015023878A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2901766A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2015013414A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2669922C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014146492A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014146246A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
| WO2016061751A1 (en) * | 2014-10-22 | 2016-04-28 | Merck Sharp & Dohme Corp. | Ethyl n-boc piperidinyl pyrazolo pyridones as janus kinase inhibitors |
| US10766883B2 (en) | 2016-12-14 | 2020-09-08 | Merck Sharp & Dohme Corp. | Aminopyrazoles as janus kinase inhibitors |
| BR112021018168B1 (pt) | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| CN111499592B (zh) * | 2020-03-14 | 2023-06-23 | 江苏省农用激素工程技术研究中心有限公司 | 5-氨甲基糖精的合成方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2759227B2 (ja) | 1990-09-28 | 1998-05-28 | 大鵬薬品工業株式会社 | ピラゾロピリジン誘導体 |
| IL146474A0 (en) | 1999-06-03 | 2002-07-25 | Knoll Gmbh | Benzothiazinone and benzoxazinone compounds |
| US7285658B2 (en) | 2002-02-28 | 2007-10-23 | Biota, Inc. | Nucleotide mimics and their prodrugs |
| JP4414881B2 (ja) | 2002-05-31 | 2010-02-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾール化合物およびこれを含んでなる医薬組成物 |
| JP4139185B2 (ja) | 2002-10-17 | 2008-08-27 | 京セラ株式会社 | 配線基板の製造方法 |
| WO2007084557A2 (en) * | 2006-01-17 | 2007-07-26 | Vertex Pharmaceuticals Incorporated | Azaindoles useful as inhibitors of janus kinases |
| JP5287253B2 (ja) * | 2007-01-12 | 2013-09-11 | アステラス製薬株式会社 | 縮合ピリジン化合物 |
| EP2451813B1 (en) | 2009-07-08 | 2014-10-01 | Leo Pharma A/S | Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| MX354212B (es) | 2010-03-10 | 2018-02-19 | Incyte Corp | Derivados de piperidin-4-il azetidina como inhibidores de janus cinasa 1 (jak1). |
| CA2830882C (en) | 2011-03-22 | 2021-03-16 | Dinesh Barawkar | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| AU2012312305B2 (en) * | 2011-09-22 | 2016-11-17 | Merck Sharp & Dohme Corp. | Acyclic cyanoethylpyrazoles as janus kinase inhibitors |
| CN104507940B (zh) | 2012-06-01 | 2017-01-25 | 武田药品工业株式会社 | 杂环化合物 |
| WO2014146246A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
-
2014
- 2014-03-19 CN CN201480016754.4A patent/CN105189497B/zh not_active Expired - Fee Related
- 2014-03-19 JP JP2016503522A patent/JP6322275B2/ja active Active
- 2014-03-19 MX MX2015013414A patent/MX2015013414A/es unknown
- 2014-03-19 WO PCT/CN2014/000298 patent/WO2014146492A1/en not_active Ceased
- 2014-03-19 RU RU2015144483A patent/RU2669922C2/ru not_active IP Right Cessation
- 2014-03-19 EP EP14767458.4A patent/EP2976338B1/en active Active
- 2014-03-19 KR KR1020157025519A patent/KR20150130311A/ko not_active Withdrawn
- 2014-03-19 US US14/778,052 patent/US9957265B2/en active Active
- 2014-03-19 CA CA2901766A patent/CA2901766A1/en not_active Abandoned
- 2014-03-19 BR BR112015023878A patent/BR112015023878A2/pt not_active Application Discontinuation
- 2014-03-19 AU AU2014234908A patent/AU2014234908B2/en not_active Ceased